Gapping down
In reaction to disappointing earnings/guidance:
- TWTR -19.3%, NOK -18.4%, NTGR -12.4%, FTI -9.7%, EBAY -7.9%, GGG -7.9%, BAX -5.6%, F -4.6%, RBS -3.5%, LMAT -2.8%, SWK -2.6%, KRA -2.5%, DHR -2.5%, GNC -2.1%, ADS -2%, MMM -1.7%, ARI -1.4%, CUZ -1.4%, WPG -1.1%, CVBF -1.1%, HSY -1.1%, PKG -0.8%, GPI -0.7%, MSM -0.6%
Other news:
- OPGN -56.3% (prices offering of 4.7 mln common units at $2.00 per unit)
- TXMD -15.8% (launches public offering of 22.0 mln shares of common stock and reports prelim Q3 revs of $7.82-8.3 mln vs. $7.85 mln S&P Capital IQ Consensus)
- ACOR -7.6% (implements corporate restructuring, provides third quarter 2019 update)
- PACB -3.6% (UK's CMA provisionally finds that the proposed merger between Illumina (ILMN) and PacBio will result in a substantial loss of competition)
- PINS -1.2% (TWTR sympathy) GM -1.1% (following F earnings)
- SNAP -1.1% (TWTR sympathy)
- FB -0.9% (TWTR sympathy)
Analyst comments:
- ARWR -2.1% (downgraded to Neutral from Outperform at Robert W. Baird)
- IRBT -1.4% (downgraded to Neutral from Buy at BofA/Merrill)
